Suppr超能文献

精神分裂症和精神障碍住院后30天再入院费用及发生率的预测因素:一项全国性分析

Predictors of Cost and Incidence of 30-Day Readmissions Following Hospitalizations for Schizophrenia and Psychotic Disorders: A Nationwide Analysis.

作者信息

Wani Rajvi J, Kathe Niranjan J, Klepser Donald G

机构信息

College of Education and Human Sciences, University of Nebraska-Lincoln (Dr Wani); Division of Pharmaceutical Evaluation and Policy, Department of Pharmacy Practice, University of Arkansas for Medical Sciences, College of Pharmacy, Little Rock (Dr Kathe); and Department of Pharmacy Practice and Science, College of Pharmacy, University of Nebraska Medical Center, Omaha (Dr Klepser).

出版信息

Qual Manag Health Care. 2019 Jul/Sep;28(3):130-138. doi: 10.1097/QMH.0000000000000223.

Abstract

BACKGROUND

Schizophrenia and psychotic disorders (SPDs)-related hospitalizations are the second leading cause of 30-day readmission. This study assessed the effect of patient and hospital-level factors on readmission costs following index hospital discharges for SPDs.

METHODS

2014 Nationwide Readmissions Database was used to identify SPD-related discharges between January 1, 2014, and November 30, 2014. Multivariable logistic regression was used to estimate patient and hospital-level predictors for readmissions. A two part model was used to estimate the predictors of readmission and associated cost for index hospital discharges with SPDs.

RESULTS

A total of 77 625 of 343 579 (22%) index hospital discharges for SPDs resulted in readmissions. The average index and readmission costs were $9285 and $8593, respectively. Being 25 to 44 years old (odds ratio: 1.14), with nonmental comorbidities (odds ratio: 1.52), and admitted in private hospitals (odds ratio: 1.24) had significantly higher odds of readmission rates. Being males ($105), 25 to 44 years of age ($99), urban residents ($312), Medicare enrollees ($713 over privately insured), high-income area residents ($393), having multiple comorbidities ($923), and those admitted in large metropolitan ($680) and government-owned hospitals ($417) had higher costs of readmission.

CONCLUSION

The high SPD-related readmission rates can be reduced by providing integrated behavioral health services for this high-risk cohort.

摘要

背景

精神分裂症及精神障碍(SPD)相关住院治疗是30天再入院的第二大主要原因。本研究评估了患者和医院层面因素对SPD指数住院出院后再入院费用的影响。

方法

使用2014年全国再入院数据库来识别2014年1月1日至2014年11月30日期间与SPD相关的出院病例。采用多变量逻辑回归来估计再入院的患者和医院层面预测因素。使用两部分模型来估计SPD指数住院出院的再入院预测因素及相关费用。

结果

在343579例SPD指数住院出院病例中,共有77625例(22%)导致再入院。指数住院和再入院的平均费用分别为9285美元和8593美元。年龄在25至44岁(比值比:1.14)、患有非精神合并症(比值比:1.52)以及在私立医院住院(比值比:1.24)的患者再入院率显著更高。男性(多105美元)、25至44岁(多99美元)、城市居民(多312美元)、医疗保险参保者(比私人保险者多713美元)、高收入地区居民(多393美元)、患有多种合并症(多923美元)以及在大城市(多680美元)和公立医院(多417美元)住院的患者再入院费用更高。

结论

通过为这一高危人群提供综合行为健康服务,可以降低与SPD相关的高再入院率。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验